LUTEON Trademark

Trademark Overview

On Friday, January 23, 2026, a trademark application was filed for LUTEON with the United States Patent and Trademark Office. The USPTO has given the LUTEON trademark a serial number of 79444703. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 26, 2026. This trademark is owned by Telix Pharmaceuticals Limited. The LUTEON trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research; clinical trials; clinical research; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals; all the foregoing in relation to the development of pharmaceuticals for use in relation to the diagnosis, monitoring or treatment of kidney cancer
luteon

General Information

Serial Number79444703
Word MarkLUTEON
Filing DateFriday, January 23, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, February 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific research; clinical trials; clinical research; testing of pharmaceuticals; laboratory testing; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals; all the foregoing in relation to the development of pharmaceuticals for use in relation to the diagnosis, monitoring or treatment of kidney cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 19, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Thursday, February 26, 2026SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, March 19, 2026LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, March 20, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 20, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

luteon research pharmaceuticals clinical development testing relation diagnosis monitoring kidney cancer